[1]
2026. In silico targeting of CYP19A1 and PTPN1 by Nigellidine: A network-based exploration of its antidiabetic pathway interactions. Indian Journal of Biochemistry and Biophysics (IJBB). 63, 5 (Apr. 2026), 506–519. DOI:https://doi.org/10.56042/ijbb.v63i5.22700.